Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Longhurst

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Immunobiology|January 11, 2022
Management of pregnancy in hereditary angioedema in a resource constrained setting: Our experience at Chandigarh, North IndiaAnkur Kumar Jindal, Prabal Barman, Sanchi Chawla, et al.
Clinical Immunology (Orlando, Fla.)|November 28, 2023
Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospectsRohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|September 17, 2021
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 10, 2018
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaYing Zhang, Michael A Tortorici, Dipti Pawaskar, et al.
Immunobiology|November 16, 2020
Successful perioperative management of three patients with hereditary angioedema without C1 esterase inhibitor therapy: A developing country perspectiveAnkur Kumar Jindal, Ankita Singh, Gummadi Anjani, et al.
Thrombosis and Haemostasis|November 17, 2020
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic ParametersAvner Reshef, Donald Levy, Hilary Longhurst, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 21, 2025
Factors contributing to non-compliance with on-demand treatment guidelines in hereditary angioedemaStephen D Betschel, Jonny Peter, William Lumry, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like DisordersRohan Ameratunga, Emily S J Edwards, Klaus Lehnert, et al.
Clinical and Experimental Immunology|August 11, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19Rohan Ameratunga, Emily Mears, Euphemia Leung, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 14, 2022
Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case seriesMarcus Maurer, Markus Magerl, Emel Aygören-Pürsün, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Immunobiology|January 11, 2022
Management of pregnancy in hereditary angioedema in a resource constrained setting: Our experience at Chandigarh, North IndiaAnkur Kumar Jindal, Prabal Barman, Sanchi Chawla, et al.
Clinical Immunology (Orlando, Fla.)|November 28, 2023
Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospectsRohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|September 17, 2021
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 10, 2018
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaYing Zhang, Michael A Tortorici, Dipti Pawaskar, et al.
Immunobiology|November 16, 2020
Successful perioperative management of three patients with hereditary angioedema without C1 esterase inhibitor therapy: A developing country perspectiveAnkur Kumar Jindal, Ankita Singh, Gummadi Anjani, et al.
Thrombosis and Haemostasis|November 17, 2020
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic ParametersAvner Reshef, Donald Levy, Hilary Longhurst, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 21, 2025
Factors contributing to non-compliance with on-demand treatment guidelines in hereditary angioedemaStephen D Betschel, Jonny Peter, William Lumry, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like DisordersRohan Ameratunga, Emily S J Edwards, Klaus Lehnert, et al.
Clinical and Experimental Immunology|August 11, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19Rohan Ameratunga, Emily Mears, Euphemia Leung, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 14, 2022
Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case seriesMarcus Maurer, Markus Magerl, Emel Aygören-Pürsün, et al.
Pageof 8